Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
31%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
FHLC
349
HOLDINGS
3%
ALSO IN THNR
THNR
18
HOLDINGS
56%
ALSO IN FHLC
SECTOR DRIFT (FHLC minus THNR)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in THNR |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 14.6% | 11.5% | 11.5% |
|
ABBVIE INC | 6.7% | 5.6% | 5.6% |
|
MERCK & CO. INC. | 4.8% | 5.0% | 4.8% |
|
AMGEN INC | 3.2% | 6.1% | 3.2% |
|
GILEAD SCIENCES INC | 2.7% | 5.7% | 2.7% |
FHLC Overweight Relative to THNR
|
JOHNSON & JOHNSON | 8.5% |
|
UNITEDHEALTH GROUP INC | 4.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.3% |
|
ELI LILLY & CO | 3.1% |
|
ABBOTT LABORATORIES | 2.4% |
|
INTUITIVE SURGICAL INC | 2.0% |
|
DANAHER CORP | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% |
 |
MEDTRONIC PLC | 1.6% |
FHLC Underweight Relative to THNR
 |
NOVO-NORDISK A/S-SPONS ADR | -8.7% |
 |
ASTRAZENECA PLC | -6.0% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -5.0% |
 |
CHINA PHARMACEUTICAL GROUP | -4.7% |
|
REGENERON PHARMACEUTICALS | -4.6% |
 |
INNOVENT BIOLOGICS, INC. | -4.5% |
|
VIKING THERAPEUTICS, INC. | -4.1% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.4% |
|
ZEALAND PHARMA A/S | -3.4% |
|
PFIZER INC | -3.2% |